ADAGE CAPITAL PARTNERS GP, L.L.C. - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 203 filers reported holding IMMUNOMEDICS INC in Q2 2018. The put-call ratio across all filers is 1.35 and the average weighting 0.5%.

Quarter-by-quarter ownership
ADAGE CAPITAL PARTNERS GP, L.L.C. ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q3 2020$102,036,000
+1589.1%
1,200,000
+313.8%
0.26%
+1861.5%
Q3 2018$6,041,000
+70.1%
290,000
+93.3%
0.01%
+62.5%
Q2 2018$3,551,000
+57.8%
150,000
-6.8%
0.01%
+60.0%
Q3 2017$2,251,000
-76.6%
161,000
-85.2%
0.01%
-79.2%
Q2 2017$9,634,000
+56.7%
1,091,000
+14.8%
0.02%
+60.0%
Q1 2017$6,147,000950,0000.02%
Other shareholders
IMMUNOMEDICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Avoro Capital Advisors LLC 17,714,461$368,992,00016.94%
ACUTA CAPITAL PARTNERS, LLC 2,055,500$42,816,00015.27%
Foresite Capital Management III, LLC 2,691,729$56,069,00012.37%
Foresite Capital Management IV, LLC 1,231,543$25,653,0008.41%
NEXTHERA CAPITAL LP 1,398,577$29,132,0005.58%
Palo Alto Investors LP 5,013,764$104,437,0004.22%
Ghost Tree Capital, LLC 883,823$18,410,0003.91%
First Light Asset Management, LLC 1,151,622$23,988,0003.87%
DLD Asset Management, LP 3,403,000$70,918,0003.51%
RA Capital Management 3,119,778$64,985,0003.47%
View complete list of IMMUNOMEDICS INC shareholders